Login or sign up
For business

Savira pharmaceuticals

4.0· 8 reviews
Average ratingGreat
4.0/ 5

Based on 8 reviews

538%
425%
338%
20%
10%
Ask AI

Ask AI about Savira pharmaceuticals

Generated with AI from 8 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Savira pharmaceuticals

Savira pharmaceuticals GmbH was founded in July 2009 by the European Molecular Biology Laboratory (EMBL), onepharm Research and Development GmbH, private investors, and management. Led by CEO Oliver Szolar and CSO Helmut Buschmann, a seasoned management team combines scientific, technological, and business experience in the pharmaceutical industry.

Savira follows the biotech business model, turning capital and public grants into the preclinical and clinical development of a portfolio of anti-influenza drug candidates. Savira thus strives to create a sustainable pipeline, generate value for shareholders, improve quality of life for people suffering from influenza, and add to the arsenal of antivirals thus improving influenza pandemic preparedness.

Website
savira.at